AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2018
Jan 16, 2018
32566_dirs_2018-01-16_9bbe2c9c-73e3-4450-9385-55d1c08377c0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2018-01-12
Reporting Person: MARSH RICHARD M (E.V.P., General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-10-04 | Common Stock | G | 1500 | $0.0 | Disposed | 136385 | Direct |
| 2018-01-05 | Common Stock | G | 3000 | $0.0 | Disposed | 133753 | Direct |
| 2018-01-12 | Common Stock | S | 13759 | $36.25 | Disposed | 119994 | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2